• No se han encontrado resultados

Problemas especiales

N/A
N/A
Protected

Academic year: 2020

Share "Problemas especiales"

Copied!
9
0
0

Texto completo

Loading

Figure

Cuadro 6-I. Dosis de medicamentos en pacientes sometidos a un programa de diálisis.
Cuadro 6-III. Efectos de la hiperinsulinemia. • Retención renal de sodio (antinatriurético) • Estímulo de la actividad de la bomba Na+ - H+
Cuadro 6-IV. Prueba de catecolaminas urinarias (mg/24 h o µg/mg/cr). Adulto normal Feocromocitoma Catecolaminas libres < 0.1 0.1 - 10 Metanefrinas < 1.2 1.5 - 100 Ácido vainillilmandélico < 6.5 7.0 - 600

Referencias

Documento similar

You may wish to take a note of your Organisation ID, which, in addition to the organisation name, can be used to search for an organisation you will need to affiliate with when you

Where possible, the EU IG and more specifically the data fields and associated business rules present in Chapter 2 –Data elements for the electronic submission of information

The 'On-boarding of users to Substance, Product, Organisation and Referentials (SPOR) data services' document must be considered the reference guidance, as this document includes the

In medicinal products containing more than one manufactured item (e.g., contraceptive having different strengths and fixed dose combination as part of the same medicinal

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in

Products Management Services (PMS) - Implementation of International Organization for Standardization (ISO) standards for the identification of medicinal products (IDMP) in

This section provides guidance with examples on encoding medicinal product packaging information, together with the relationship between Pack Size, Package Item (container)

Package Item (Container) Type : Vial (100000073563) Quantity Operator: equal to (100000000049) Package Item (Container) Quantity : 1 Material : Glass type I (200000003204)